Intelligencia, founded with the mission to optimize and de-risk clinical development, leverages proprietary and expertly curated data to pioneer the use of Machine Learning algorithms. Their core vision is to enhance the probability of success in drug development by harnessing the power of data and AI. Intelligencia offers SaaS products such as the Portfolio Optimizer and Clinical Development Insights, which provide actionable insights to pharmaceutical companies and clinical researchers.
Notable affiliated people and investors include experts in AI and clinical development, although specific names are not provided. Key achievements include receiving a patent for their accurate and transparent Probability of Success algorithm. Intelligencia's impact is significant in the pharmaceutical industry, where their AI-driven solutions help reduce risks and improve outcomes in clinical trials, thereby accelerating the development of new therapies.
